Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 100%
fibroma
95%
—
uterine atresia —
79%
benign neoplasms
63%
—
vaginal atresia —
75%
multiple fibroids
21%
—
intrauterine septum —
68%
monthly abundant and prolonged
8%
—
doubling of the uterus and vagina —
67%
very abundant monthly
8%
—
hematocolpos —
59%
cystic mastopathy
7%
—
pain in the vagina
1%
56%
mastopathy
7%
—
lack of menstruation
1%
49%
diffuse mastopathy
7%
—
female pelvic organs
2%
49%
fibrous mastopathy
7%
—
monthly gas scanty —
47%
endometriosis
6%
—
lower abdominal pain
1%
47%
endometrial hyperplasia
6%
—
ureaplasmosis in women —
43%
endometrioid ovarian cyst
6%
—
spastic dysmenorrhea —
43%
dysfunctional uterine bleeding
5%
—
cervical canal atresia —
43%
bleeding
5%
—
hematosalpinx —
41%
polyps
4%
—
abdominal pain during menstruation —
41%
uterine cyst
4%
—
pain in the lower abdomen during menstruation —
40%
growth of uterine fibroids
4%
—
cervical canal stenosis —
40%
ovarian cysts
4%
—
feeling of heaviness in the lower abdomen —
40%
bleeding uterine
4%
—
heaviness in the lower abdomen —
40%
uterine polyps
4%
—
cramping pain in the lower abdomen —
39%
profuse uterine bleeding
3%
—
there was a caesarean section —
39%
infertility female
3%
—
saddle uterus —
39%
hot rush with sweating
3%
—
ureaplasmosis and mycoplasmosis —
39%
papillomas on the neck
3%
—
monthly painful
3%
42%
hyperplasia of endometrium of uterus
3%
—
history of surgery
1%
39%
desire for fresh air
3%
—
vaginal discharge
1%
39%
menstruation irregular
3%
—
ureaplasmosis —
38%
anemia
3%
—
hematometer —
38%
adenomyosis
3%
—
pregnancy
2%
40%
menopause
3%
—
mycoplasmosis in women —
37%
endometrial polyps
3%
—
unpleasant odor from the vagina —
37%
thyroid nodes
3%
—
vaginal discharge with an unpleasant odor —
37%
menopause sweating
3%
—
congenital abnormalities of the ureter —
37%
uterine fibroids
2%
—
abdominal pain
1%
38%
hypotension
2%
—
menstruation disorder
1%
37%
uterine fibroids during pregnancy
2%
—
white with an unpleasant odor —
36%
painful swelling
2%
—
delay menstruation —
35%
oncology in the anamnesis
2%
—
teenage pregnancy —
33%
responsible
2%
—
monthly short —
33%
enlargement of the thyroid gland
2%
—
doubling of the intestine —
33%
menopause diseases
2%
—
primary amenorrhea —
33%
hot flashes
2%
—
worse during menstruation —
32%
clots menstruation
2%
—
abnormalities of uterine development —
32%
guilt
2%
—
atresia of the anus and rectum —
32%
submucous uterine fibroids
2%
—
multiple warts —
32%
miscarriage
2%
—
stomach cramping pain —
32%
chilly
2%
—
spastic abdominal pain —
32%
monthly prolonged
2%
—
constipation
1%
33%
necrosis of the myomatous node
2%
—
discharge with an unpleasant smell —
32%
cervical fibroids
2%
—
blood diseases
2%
33%
gynecological operations in the anamnesis —
31%
aortic coarctation —
31%
a difficult life —
30%
pain during sexual intercourse
1%
31%
consequences of herpes —
30%
frequent constipation —
30%
mycoplasma —
30%
stopped menstruation —
30%
natural childbirth —
29%
heaviness in the abdomen
1%
30%
abdominal pain constipation
1%
30%
feeling of heaviness in the stomach
1%
30%
pain in the uterus
2%
30%
enlargement of the uterus
2%
30%
anomalies of kidney development —
28%
often abdominal pain —
28%
STDs —
28%
aortic stenosis —
28%
operative delivery —
27%
gastrointestinal problems
1%
28%
complications of childbirth —
27%
spasmodic pain —
26%
urination painful
0%
26%
deterioration during pregnancy
1%
27%
there are no complaints
1%
27%
speeded up urination
1%
27%
warts
1%
26%
pregnancy complications —
25%
effects of puberty —
24%
genital neoplasms
1%
25%
herpes —
24%
early development
0%
23%
pain in the intestines
0%
23%
impaired uterine function
2%
24%
appendages of the uterus
2%
24%
presses —
21%
impaired lung function
0%
20%
consequences of surgery
0%
20%
diseases of the gastrointestinal tract
0%
20%
consequences of infection —
20%
drug disease
1%
19%
inflammation
1%
18%
consequences of taking medications
1%
18%
increased
1%
18%
patient's condition
2%
18%
oncology
29%
41%